KEENAN SMART: Open Payments
NPI 1790120483 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 122 payments from 14 companies in 2025. Trend: 2023 $947 · 2024 $1,151 · 2025 $1,397
Food & beverage: $1,397
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 44 | $351 |
| ABBVIE INC. | 31 | $260 |
| Otsuka America Pharmaceutical, Inc. | 21 | $255 |
| Supernus Pharmaceuticals, Inc. | 5 | $99 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| Janssen Pharmaceuticals, Inc | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Tris Pharma Inc | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Corium, LLC | 1 | $35 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Qelbree, Jornay PM, ABILIFY MAINTENA, SPRAVATO, Auvelity.
Industry payments across OK — which companies pay providers there.
